Fernandez AP

Title : The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease - Serrano_2017_J.Psychiatry.Neurosci_42_59

Author(s) : Serrano MP , Herrero-Labrador R , Futch HS , Serrano J , Romero A , Fernandez AP , Samadi A , Unzeta M , Marco-Contelles J , Martinez-Murillo R

Ref : J Psychiatry Neurosci , 42 :59 , 2017

Abstract :

PubMedSearch : Serrano_2017_J.Psychiatry.Neurosci_42_59

PubMedID: 27636528

Title : Nitric oxide: target for therapeutic strategies in Alzheimer's disease - Fernandez_2010_Curr.Pharm.Des_16_2837

Author(s) : Fernandez AP , Pozo-Rodrigalvarez A , Serrano J , Martinez-Murillo R

Ref : Curr Pharm Des , 16 :2837 , 2010

Abstract :

PubMedSearch : Fernandez_2010_Curr.Pharm.Des_16_2837

PubMedID: 20698819

Fernandez AP

References (2)

1. The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease - Serrano_2017_J.Psychiatry.Neurosci_42_59

2. Nitric oxide: target for therapeutic strategies in Alzheimer's disease - Fernandez_2010_Curr.Pharm.Des_16_2837